Gastrointestinal (GI) Society
As the Canadian lead in providing trusted, evidence-based information on all areas of the gastrointestinal tract, the GI Society is committed to improving the lives of people with GI and liver conditions, supporting research, advocating for appropriate patient access to health care, and promoting gastrointestinal and liver health.
During 2017, GSK funded the GI Society with:
- $25,000 in core funding
GSK’s contributions to the GI Society represent 2.6% of the organization’s total revenue for 2017.